Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neo40 in HFpEF
NCT03289481Phase 1Completed
- Sponsor
- MaineHealth
- Start
- Jun 2017
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in heart failure with preserved ejection fraction (HFpEF) (2 arms), sponsored by MaineHealth. Primary endpoints: Time on Treadmill at 1 week, Metabolic Equivalents at 1 week and 2 more. Started Jun 2017; status: completed.
02
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT03289481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03289481.